Hera Health Solutions Inc., is a privately held corporation. Hera is a pharmaceutical device company specializing in the research, development, and commercialization of long acting treatments through its proprietary bioerodible drug delivery platform. The company's lead product under development, Eucontra, is a long acting biodegradable contraceptive implant.
Investment in the company is currently open for Angel, Private, and Institutional investors. Investors are invited to review our current investment offering. Hera Health Solutions Inc., is offering investments to verified accredited investors. Prospective investors interested in learning more about the company and its products, including the risks of investing, should contact us.
Information on our website has has been prepared in good faith by the Company. With respect to the projections, forecasts, pricing, sales, budget, and market information contained in the Overview, the Company represents only that such information was prepared in good faith and that the Company believes that there is a reasonable basis for such information. Although the information on our website is believed by the Company to be complete and accurate, all such information is subject to change at any time, and the Company expressly disclaims any and all liability for any information, representations or statements (express or implied) contained in, and/or for any omissions.